GO:0003723 | RNA binding | 4.38e-04 | 1.00e+00 | 3.398 | 4 | 22 | 247 |
GO:0017005 | 3'-tyrosyl-DNA phosphodiesterase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0052565 | response to defense-related host nitric oxide production | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0004824 | lysine-tRNA ligase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0006406 | mRNA export from nucleus | 2.01e-03 | 1.00e+00 | 4.887 | 2 | 7 | 44 |
GO:0008074 | guanylate cyclase complex, soluble | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0003747 | translation release factor activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 2 | 2 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0005515 | protein binding | 3.33e-03 | 1.00e+00 | 0.922 | 12 | 198 | 4124 |
GO:0016032 | viral process | 3.38e-03 | 1.00e+00 | 2.605 | 4 | 30 | 428 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 2 | 3 |
GO:0000778 | condensed nuclear chromosome kinetochore | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 2 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0001649 | osteoblast differentiation | 5.58e-03 | 1.00e+00 | 4.137 | 2 | 5 | 74 |
GO:0097452 | GAIT complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 4 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0000012 | single strand break repair | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0030529 | ribonucleoprotein complex | 6.81e-03 | 1.00e+00 | 3.989 | 2 | 5 | 82 |
GO:0010467 | gene expression | 7.49e-03 | 1.00e+00 | 2.283 | 4 | 49 | 535 |
GO:0060087 | relaxation of vascular smooth muscle | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0004521 | endoribonuclease activity | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 3 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0060744 | mammary gland branching involved in thelarche | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0000127 | transcription factor TFIIIC complex | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 3 | 5 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 3 | 5 |
GO:0005654 | nucleoplasm | 8.04e-03 | 1.00e+00 | 1.894 | 5 | 68 | 876 |
GO:0050847 | progesterone receptor signaling pathway | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0004383 | guanylate cyclase activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0008409 | 5'-3' exonuclease activity | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 7 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 7 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0051382 | kinetochore assembly | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 7 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 4 | 8 |
GO:0006379 | mRNA cleavage | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 3 | 9 |
GO:0005095 | GTPase inhibitor activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0006182 | cGMP biosynthetic process | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0008143 | poly(A) binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 10 |
GO:0000398 | mRNA splicing, via spliceosome | 1.60e-02 | 1.00e+00 | 3.347 | 2 | 15 | 128 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 4 | 11 |
GO:0006479 | protein methylation | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 2 | 11 |
GO:0000132 | establishment of mitotic spindle orientation | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 12 |
GO:0004527 | exonuclease activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 4 | 12 |
GO:0007263 | nitric oxide mediated signal transduction | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 12 |
GO:0060749 | mammary gland alveolus development | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0046580 | negative regulation of Ras protein signal transduction | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 14 |
GO:0016597 | amino acid binding | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 15 |
GO:0000281 | mitotic cytokinesis | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 3 | 15 |
GO:0005640 | nuclear outer membrane | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 1 | 17 |
GO:0008380 | RNA splicing | 2.58e-02 | 1.00e+00 | 2.980 | 2 | 21 | 165 |
GO:0006378 | mRNA polyadenylation | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 18 |
GO:0005634 | nucleus | 3.02e-02 | 1.00e+00 | 0.852 | 9 | 158 | 3246 |
GO:0034080 | CENP-A containing nucleosome assembly | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0071346 | cellular response to interferon-gamma | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 2 | 21 |
GO:0030331 | estrogen receptor binding | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 2 | 22 |
GO:0000049 | tRNA binding | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 2 | 23 |
GO:0005743 | mitochondrial inner membrane | 3.58e-02 | 1.00e+00 | 2.724 | 2 | 9 | 197 |
GO:0005525 | GTP binding | 3.58e-02 | 1.00e+00 | 2.724 | 2 | 12 | 197 |
GO:0008180 | COP9 signalosome | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 6 | 24 |
GO:0008033 | tRNA processing | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 2 | 25 |
GO:0007259 | JAK-STAT cascade | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 2 | 25 |
GO:0010827 | regulation of glucose transport | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 7 | 25 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 6 | 29 |
GO:0016579 | protein deubiquitination | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 1 | 29 |
GO:0032154 | cleavage furrow | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 3 | 30 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 6 | 31 |
GO:0008015 | blood circulation | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 1 | 31 |
GO:0007077 | mitotic nuclear envelope disassembly | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 9 | 32 |
GO:0046872 | metal ion binding | 4.83e-02 | 1.00e+00 | 1.479 | 4 | 24 | 934 |
GO:0017148 | negative regulation of translation | 4.95e-02 | 1.00e+00 | 4.302 | 1 | 5 | 33 |
GO:0000786 | nucleosome | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 2 | 34 |
GO:0071407 | cellular response to organic cyclic compound | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 1 | 34 |
GO:0031124 | mRNA 3'-end processing | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 4 | 35 |
GO:0008645 | hexose transport | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 8 | 36 |
GO:0003743 | translation initiation factor activity | 5.54e-02 | 1.00e+00 | 4.137 | 1 | 8 | 37 |
GO:0008237 | metallopeptidase activity | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 3 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 5 | 38 |
GO:0006396 | RNA processing | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 4 | 40 |
GO:0006508 | proteolysis | 6.07e-02 | 1.00e+00 | 2.302 | 2 | 11 | 264 |
GO:0000775 | chromosome, centromeric region | 6.12e-02 | 1.00e+00 | 3.989 | 1 | 6 | 41 |
GO:0008217 | regulation of blood pressure | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 2 | 42 |
GO:0004843 | ubiquitin-specific protease activity | 6.84e-02 | 1.00e+00 | 3.823 | 1 | 2 | 46 |
GO:0015758 | glucose transport | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 8 | 48 |
GO:0006334 | nucleosome assembly | 7.56e-02 | 1.00e+00 | 3.674 | 1 | 4 | 51 |
GO:0005643 | nuclear pore | 7.56e-02 | 1.00e+00 | 3.674 | 1 | 12 | 51 |
GO:0005739 | mitochondrion | 7.58e-02 | 1.00e+00 | 1.567 | 3 | 32 | 659 |
GO:0006302 | double-strand break repair | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 5 | 52 |
GO:0000278 | mitotic cell cycle | 8.22e-02 | 1.00e+00 | 2.052 | 2 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 8.35e-02 | 1.00e+00 | 2.038 | 2 | 17 | 317 |
GO:0008584 | male gonad development | 8.41e-02 | 1.00e+00 | 3.514 | 1 | 1 | 57 |
GO:0003697 | single-stranded DNA binding | 8.41e-02 | 1.00e+00 | 3.514 | 1 | 4 | 57 |
GO:0042826 | histone deacetylase binding | 8.55e-02 | 1.00e+00 | 3.489 | 1 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 8.98e-02 | 1.00e+00 | 3.416 | 1 | 5 | 61 |
GO:0006415 | translational termination | 9.26e-02 | 1.00e+00 | 3.369 | 1 | 2 | 63 |
GO:0030308 | negative regulation of cell growth | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 3 | 70 |
GO:0016363 | nuclear matrix | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 10 | 73 |
GO:0015630 | microtubule cytoskeleton | 1.09e-01 | 1.00e+00 | 3.118 | 1 | 5 | 75 |
GO:0044822 | poly(A) RNA binding | 1.19e-01 | 1.00e+00 | 1.289 | 3 | 45 | 799 |
GO:0003690 | double-stranded DNA binding | 1.20e-01 | 1.00e+00 | 2.971 | 1 | 6 | 83 |
GO:0005635 | nuclear envelope | 1.20e-01 | 1.00e+00 | 2.971 | 1 | 6 | 83 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 5 | 84 |
GO:0043524 | negative regulation of neuron apoptotic process | 1.23e-01 | 1.00e+00 | 2.937 | 1 | 2 | 85 |
GO:0020037 | heme binding | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 3 | 88 |
GO:0008017 | microtubule binding | 1.39e-01 | 1.00e+00 | 2.747 | 1 | 9 | 97 |
GO:0006413 | translational initiation | 1.42e-01 | 1.00e+00 | 2.717 | 1 | 6 | 99 |
GO:0005769 | early endosome | 1.55e-01 | 1.00e+00 | 2.578 | 1 | 3 | 109 |
GO:0042981 | regulation of apoptotic process | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 1.63e-01 | 1.00e+00 | 2.501 | 1 | 8 | 115 |
GO:0004872 | receptor activity | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 4 | 116 |
GO:0003924 | GTPase activity | 1.68e-01 | 1.00e+00 | 2.452 | 1 | 7 | 119 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.76e-01 | 1.00e+00 | 2.381 | 1 | 4 | 125 |
GO:0006184 | GTP catabolic process | 1.82e-01 | 1.00e+00 | 2.324 | 1 | 7 | 130 |
GO:0005759 | mitochondrial matrix | 1.94e-01 | 1.00e+00 | 2.228 | 1 | 7 | 139 |
GO:0005737 | cytoplasm | 1.95e-01 | 1.00e+00 | 0.569 | 6 | 127 | 2633 |
GO:0044212 | transcription regulatory region DNA binding | 1.99e-01 | 1.00e+00 | 2.187 | 1 | 13 | 143 |
GO:0005622 | intracellular | 2.01e-01 | 1.00e+00 | 2.167 | 1 | 2 | 145 |
GO:0001701 | in utero embryonic development | 2.12e-01 | 1.00e+00 | 2.080 | 1 | 7 | 154 |
GO:0019221 | cytokine-mediated signaling pathway | 2.34e-01 | 1.00e+00 | 1.920 | 1 | 10 | 172 |
GO:0000166 | nucleotide binding | 2.39e-01 | 1.00e+00 | 1.887 | 1 | 13 | 176 |
GO:0006412 | translation | 2.41e-01 | 1.00e+00 | 1.871 | 1 | 12 | 178 |
GO:0004842 | ubiquitin-protein transferase activity | 2.42e-01 | 1.00e+00 | 1.863 | 1 | 17 | 179 |
GO:0005975 | carbohydrate metabolic process | 2.51e-01 | 1.00e+00 | 1.807 | 1 | 10 | 186 |
GO:0016567 | protein ubiquitination | 2.53e-01 | 1.00e+00 | 1.792 | 1 | 14 | 188 |
GO:0005856 | cytoskeleton | 2.55e-01 | 1.00e+00 | 1.777 | 1 | 8 | 190 |
GO:0006281 | DNA repair | 2.70e-01 | 1.00e+00 | 1.681 | 1 | 24 | 203 |
GO:0043234 | protein complex | 2.78e-01 | 1.00e+00 | 1.632 | 1 | 13 | 210 |
GO:0019899 | enzyme binding | 2.78e-01 | 1.00e+00 | 1.632 | 1 | 7 | 210 |
GO:0003682 | chromatin binding | 3.25e-01 | 1.00e+00 | 1.369 | 1 | 15 | 252 |
GO:0046982 | protein heterodimerization activity | 3.38e-01 | 1.00e+00 | 1.297 | 1 | 11 | 265 |
GO:0008285 | negative regulation of cell proliferation | 3.51e-01 | 1.00e+00 | 1.233 | 1 | 11 | 277 |
GO:0008284 | positive regulation of cell proliferation | 3.53e-01 | 1.00e+00 | 1.222 | 1 | 8 | 279 |
GO:0055085 | transmembrane transport | 4.02e-01 | 1.00e+00 | 0.985 | 1 | 13 | 329 |
GO:0007596 | blood coagulation | 4.12e-01 | 1.00e+00 | 0.941 | 1 | 13 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.13e-01 | 1.00e+00 | 0.933 | 1 | 23 | 341 |
GO:0044267 | cellular protein metabolic process | 4.24e-01 | 1.00e+00 | 0.887 | 1 | 14 | 352 |
GO:0003677 | DNA binding | 4.35e-01 | 1.00e+00 | 0.459 | 2 | 52 | 947 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.46e-01 | 1.00e+00 | 0.788 | 1 | 21 | 377 |
GO:0005783 | endoplasmic reticulum | 4.50e-01 | 1.00e+00 | 0.773 | 1 | 12 | 381 |
GO:0070062 | extracellular vesicular exosome | 4.74e-01 | 1.00e+00 | 0.251 | 3 | 51 | 1641 |
GO:0006351 | transcription, DNA-templated | 5.04e-01 | 1.00e+00 | 0.275 | 2 | 47 | 1076 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.12e-01 | 1.00e+00 | 0.514 | 1 | 29 | 456 |
GO:0005829 | cytosol | 5.36e-01 | 1.00e+00 | 0.128 | 3 | 88 | 1787 |
GO:0016020 | membrane | 5.70e-01 | 1.00e+00 | 0.109 | 2 | 56 | 1207 |
GO:0005730 | nucleolus | 5.74e-01 | 1.00e+00 | 0.097 | 2 | 74 | 1217 |
GO:0005887 | integral component of plasma membrane | 5.98e-01 | 1.00e+00 | 0.179 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 6.25e-01 | 1.00e+00 | 0.075 | 1 | 24 | 618 |
GO:0005576 | extracellular region | 6.52e-01 | 1.00e+00 | -0.026 | 1 | 15 | 663 |
GO:0006355 | regulation of transcription, DNA-templated | 6.81e-01 | 1.00e+00 | -0.135 | 1 | 31 | 715 |
GO:0044281 | small molecule metabolic process | 7.43e-01 | 1.00e+00 | -0.375 | 1 | 35 | 844 |
GO:0005524 | ATP binding | 7.63e-01 | 1.00e+00 | -0.454 | 1 | 37 | 892 |
GO:0005886 | plasma membrane | 7.89e-01 | 1.00e+00 | -0.454 | 2 | 46 | 1784 |